Letter: thromboembolic and cardiovascular events with tofacitinib in ulcerative colitis-two cases in real world clinical practice. Authors' reply.
作者信息
Sandborn William J, Panés Julian, Sands Bruce E, Reinisch Walter, Su Chinyu, Lawendy Nervin, Koram Nana, Fan Haiyun, Jones Thomas V, Modesto Irene, Quirk Daniel, Danese Silvio
机构信息
Division of Gastroenterology, University of California, San Diego, La Jolla, CA, USA.
Hospital Clínic de Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain.
出版信息
Aliment Pharmacol Ther. 2020 Jun;51(11):1209-1210. doi: 10.1111/apt.15735.
PMID:32424928
Abstract
摘要
相似文献
1
Letter: thromboembolic and cardiovascular events with tofacitinib in ulcerative colitis-two cases in real world clinical practice. Authors' reply.信件：托法替布治疗溃疡性结肠炎时的血栓栓塞和心血管事件——真实世界临床实践中的两例病例。作者回复
Aliment Pharmacol Ther. 2020 Jun;51(11):1209-1210. doi: 10.1111/apt.15735.
2
Letter: thromboembolic and cardiovascular events with tofacitinib in ulcerative colitis-two cases in real world clinical practice.
Aliment Pharmacol Ther. 2020 Jun;51(11):1208-1209. doi: 10.1111/apt.15652.
3
Letter: tofacitinib in treatment-refractory ulcerative colitis-a single centre real-world experience in Australia. Authors' reply.信件：托法替布治疗难治性溃疡性结肠炎——澳大利亚单中心真实世界经验。作者回复。
Aliment Pharmacol Ther. 2021 Aug;54(4):534-535. doi: 10.1111/apt.16505.
4
Letter: corticosteroid use alongside tofacitinib in OCTAVE Open. Authors' reply.信件：在OCTAVE开放试验中与托法替布联合使用皮质类固醇。作者回复。
Aliment Pharmacol Ther. 2020 May;51(10):997-998. doi: 10.1111/apt.15716.
5
Editorial: tofacitinib and biologics for moderate-to-severe ulcerative colitis-what is best in class? Authors' reply.社论：托法替布与生物制剂治疗中重度溃疡性结肠炎——哪一种堪称同类最佳？作者回复。
Aliment Pharmacol Ther. 2018 Feb;47(4):540-541. doi: 10.1111/apt.14486.
6
Tofacitinib in Acute Severe Ulcerative Colitis: Case Series and a Systematic Review-Authors' Reply.托法替布治疗急性重症溃疡性结肠炎：病例系列及系统评价——作者回复
Inflamm Bowel Dis. 2021 Aug 19;27(9):e107. doi: 10.1093/ibd/izab088.
7
Letter: tofacitinib in biologic-experienced ulcerative colitis-a single-centre real-world experience in Australia.信：托法替布治疗生物制剂治疗失败的溃疡性结肠炎——澳大利亚单中心真实世界经验
Aliment Pharmacol Ther. 2021 Aug;54(4):532-533. doi: 10.1111/apt.16468.
8
Efficacy of tofacitinib treatment in ulcerative colitis.托法替布治疗溃疡性结肠炎的疗效。
Gastroenterol Hepatol. 2019 Jun-Jul;42(6):403-412. doi: 10.1016/j.gastrohep.2019.03.002. Epub 2019 May 14.
9
Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis.托法替布治疗溃疡性结肠炎的诱导缓解和维持治疗。
N Engl J Med. 2017 May 4;376(18):1723-1736. doi: 10.1056/NEJMoa1606910.
10
Letter: new insights on tofacitinib dose de-escalation.信件：托法替布剂量递减的新见解
Aliment Pharmacol Ther. 2020 Mar;51(5):578. doi: 10.1111/apt.15638.
Zotero 插件